Source: Getty Images

Templeton, ICICI’s Bet on Indian Pharmaceuticals Is Paying Off

Updated on
  • ICICI Prudential overweight on drugmakers on improving outlook
  • Antique prefers large pharma on under-ownership, generics push

India’s pharmaceutical industry is helping lead an equity bull run as investors wager on a resolution to U.S. regulatory sanctions that rocked companies in the sector last year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.